0001731122-24-000375.txt : 20240307 0001731122-24-000375.hdr.sgml : 20240307 20240307173037 ACCESSION NUMBER: 0001731122-24-000375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paglia John Kenneth CENTRAL INDEX KEY: 0001627832 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40471 FILM NUMBER: 24731440 MAIL ADDRESS: STREET 1: 746 GRABLE PLACE CITY: NEWBURY PARK STATE: CA ZIP: 91320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPLASH BEVERAGE GROUP, INC. CENTRAL INDEX KEY: 0001553788 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 341720075 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1314 E LAS OLAS BLVD, SUITE 221 CITY: FORT LAUDERDALE STATE: FL ZIP: 33301 BUSINESS PHONE: 954.745.5815 MAIL ADDRESS: STREET 1: 1314 E LAS OLAS BLVD, SUITE 221 CITY: FORT LAUDERDALE STATE: FL ZIP: 33301 FORMER COMPANY: FORMER CONFORMED NAME: Canfield Medical Supply, Inc. DATE OF NAME CHANGE: 20120709 4 1 ownership.xml X0508 4 2024-02-26 0 0001553788 SPLASH BEVERAGE GROUP, INC. SBEV 0001627832 Paglia John Kenneth C/O SPLASH BEVERAGE GROUP, INC. 1314 E LAS OLAS BLVD, SUITE 221 FORT LAUDERDALE FL 33301 1 0 0 0 0 Stock options 0.5275 2024-02-26 4 A 0 600000 0.00 A 2034-02-26 Common stock 600000 600000 D The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest. Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure. The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company. /s/ John Paglia 2024-03-07